Angiotensin II increases matrix metalloproteinase 2 expression in human aortic smooth muscle cells via AT1R and ERK1/2

Experimental Biology and Medicine

Volumn 240, Issue 12, 2015, Pages 1564-1571

  Wang, Chunmao ^a   Qian, Xiangyang ^a   Sun, Xiaogang ^a   Chang, Qian ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Angiotensin II; extracellular signal regulated kinase 1 2; human aortic smooth muscle cells; matrix metalloproteinase 2; renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CANDESARTAN; GELATINASE A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; AGTR1 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN;

AORTA MEDIA; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA ANEURYSM; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; AORTA; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; AORTA; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84958246513     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370215576312     Document Type: Article

References (38)

1. G.JohanssonU.MarkstromJ.Swedenborg. Ruptured thoracic aortic aneurysms: a study of incidence and mortality rates. J Vasc Surg1995; 21: 985–8.
2. R.VisseH.Nagase. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res2003; 92: 827–39.
3. J.D.RaffettoR.A.Khalil. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol2008; 75: 14–14.
4. I.SinhaS.BethiP.CroninD.M.WilliamsK.RoelofsG.AilawadiP.K.HenkeM.J.EagletonG.M.DeebH.J.PatelR.BerguerJ.C.StanleyG.R.UpchurchJr. A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg2006; 43: 342–8.
5. A.M.SeguraR.E.LunaK.HoribaW.G.Stetler-StevensonH.A.McAllisterJrJ.T.WillersonV.J.Ferrans. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation1998; 98: 7–7.
6. G.M.LongoW.XiongT.C.GreinerY.ZhaoN.FiottiB.T.Baxter. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest2002; 110: 625–32.
7. R.W.ThompsonD.R.HolmesR.A.MertensS.LiaoM.D.BotneyR.P.MechamH.G.WelgusW.C.Parks. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest1995; 96: 318–26.
8. M.CrowtherS.GoodallJ.L.JonesP.R.BellM.M.Thompson. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg2000; 32: 575–83.
9. M.I.PatelJ.MelroseP.GhoshM.Appleberg. Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg1996; 24: 82–92.
10. V.LesauskaiteP.TanganelliC.SassiE.NeriF.DiciollaL.IvanovieneM.C.EpistolatoA.V.LalingaC.AlessandriniD.Spina. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol2001; 32: 1003–11.
11. R.M.Touyz. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol2005; 90: 449–55.
12. H.LuD.L.RateriD.BruemmerL.A.CassisA.Daugherty. Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci (Lond)2012; 123: 531–43.
13. E.MoltzerJ.EssersJ.H.van EschJ.W.Roos-HesselinkA.H.Danser. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol Ther2011; 131: 50–60.
14. A.DaughertyD.L.RateriI.F.CharoA.P.OwensD.A.HowattL.A.Cassis. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond)2010; 118: 681–9.
15. D.BruemmerA.DaughertyH.LuD.L.Rateri. Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms. Ann N Y Acad Sci2011; 1245: 7–10.
16. R.M.TouyzL.Y.DengG.HeX.H.WuE.L.Schiffrin. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens1999; 17: 907–16.
17. T.TakahashiY.KawaharaM.OkudaH.UenoA.TakeshitaM.Yokoyama. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem1997; 272: 16018–22.
18. M.LuchtefeldK.GroteC.GrothusenS.BleyN.BandlowT.SelleM.StruberA.HaverichU.BavendiekH.DrexlerB.Schieffer. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun2005; 328: 183–8.
19. S.A.HamH.LeeJ.S.HwangE.S.KangT.YooK.S.PaekJ.T.DoC.ParkJ.W.OhJ.H.KimC.W.HanH.G.Seo. Activation of peroxisome proliferator-activated receptor delta inhibits angiotensin II-induced activation of matrix metalloproteinase-2 in vascular smooth muscle cells. J Vasc Res2014; 51: 221–30.
20. E.JimenezE.Perez de la BlancaL.UrsoI.GonzalezJ.SalasM.Montiel. Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun2009; 380: 769–74.
21. M.BrowatzkiD.LarsenC.A.PfeifferS.G.GehrkeJ.SchmidtA.KranzhoferH.A.KatusR.Kranzhofer. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res2005; 42: 415–23.
22. M.WangJ.ZhangG.SpinettiL.Q.JiangR.MonticoneD.ZhaoL.ChengM.KrawczykM.TalanG.PintusE.G.Lakatta. Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol2005; 167: 1429–42.
23. R.E.PrattV.J.Dzau. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system. Circulation1996; 93: 848–52.
24. R.W.GuoL.X.YangH.WangB.LiuL.Wang. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul Pept2008; 147: 37–44.
25. M.A.de GodoyS.Rattan. Translocation of AT1- and AT2-receptors by higher concentrations of angiotensin II in the smooth muscle cells of rat internal anal sphincter. J Pharmacol Exp Ther2006; 319: 1088–95.
26. T.JingH.WangK.S.SrivenugopalG.HeJ.LiuL.MiaoY.He. Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling. Int J Mol Med2009; 24: 103–10.
27. P.BrassardF.AmiriE.L.Schiffrin. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension2005; 46: 598–606.
28. C.M.FordS.LiJ.G.Pickering. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol1999; 19: 1843–51.
29. L.ChangM.Karin. Mammalian MAP kinase signalling cascades. Nature2001; 410: 37–40.
30. M.PonsS.W.CousinsO.AlcazarG.E.StrikerM.E.Marin-Castaño. Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration. Am J Pathol2011; 178: 2665–81.
31. A.GhoshP.D.DiMustoL.K.EhrlichmanO.SadiqB.McEvoyJ.S.FutchkoP.K.HenkeJ.L.EliasonG.R.UpchurchJr. The role of extracellular signal-related kinase during abdominal aortic aneurysm formation. J Am Coll Surg2012; 215: 668–80 e.
32. R.M.TouyzM.El MabroukG.HeX.H.WuE.L.Schiffrin. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res1999; 84: 505–1.
33. Y.ZhangJ.C.NaggarC.M.WelzigD.BeasleyK.S.MoultonH.J.ParkJ.B.Galper. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol2009; 29: 1764–7.
34. A.NagasawaK.YoshimuraR.SuzukiA.MikamoO.YamashitaY.IkedaM.TsuchidaK.Hamano. Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. J Surg Res2013; 183: 472.
35. Y.H.KimS.J.LeeK.W.SeoJ.U.BaeS.Y.ParkE.K.KimS.S.BaeJ.H.KimC.D.Kim. PAF enhances MMP-2 production in rat aortic VSMCs via a beta-arrestin2-dependent ERK signaling pathway. J Lipid Res2013; 54: 2678–8.
36. L.K.EhrlichmanJ.W.FordK.J.RoelofsW.Tedeschi-FilhoJ.S.FutchkoE.RamacciottiJ.L.EliasonP.K.HenkeG.R.UpchurchJr. Gender-dependent differential phosphorylation in the ERK signaling pathway is associated with increased MMP2 activity in rat aortic smooth muscle cells. J Surg Res2010; 160: 18–2.
37. J.DeguchiM.MakuuchiT.NakaokaT.CollinsY.Takuwa. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms. Circ Res1999; 85: 565–7.
38. H.M.LeeC.K.LeeS.H.LeeH.Y.RohY.M.BaeK.Y.LeeJ.LimP.J.ParkT.K.ParkY.L.LeeK.J.WonB.Kim. p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. J Pharmacol Sci2007; 105: 74–8.